
Poster List
P001
Recent advances in research on Mycobacterial pathogenesis
Modeling co-Infection of Mycobacterium abscessus and Pseudomonas aeruginosa in lab and animal models
Esther Julian, Universitat Autònoma de Barcelona
P002
Recent advances in research on Mycobacterial pathogenesis
Microbiota modulation of mycobacteria-based immunotherapy in the orthotopic murine model of bladder cancer
Arnau Seguí Moll, Universitat Autònoma de Barcelona
P003
Clinical pathology and diagnostic advances
Increased sensitivity for Mycobacterium tuberculosis detection with the updated FluoroType MTBDR v2
Erik Svensson, Statens Serum Institut
P004
Clinical pathology and diagnostic advances
Diagnostic accuracy and operational assessment of microscopy and molecular tests for pulmonary tuberculosis in Panama
Dilcia Sambrano, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología de Panama, Ciudad del Saber, Panamá
P005
Clinical pathology and diagnostic advances
Role of the inhA_S94A Mutation on drug resistance and the spread of an Isoniazid-Resistant Tuberculosis strain
Anna Roig Guill, Tuberculosis Genomics Unit, Instituto de Biomedicina de Valencia, CSIC, Valencia, 46011 Spain
P006
Clinical pathology and diagnostic advances
Diagnostic capacity and Biosafety practices for Tuberculosis: Assessment of the Portuguese National Laboratory Network
Ana Rita Macedo, National Reference Laboratory for Mycobacteria, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge, Portugal
P007
Clinical pathology and diagnostic advances
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers
Margo Maex, Sciensano, Brussels, Belgium
P008
Clinical pathology and diagnostic advances
Evaluating the performance of broth microdilution for the detection of rifampicin-resistant tuberculosis caused by borderline rpoB mutants
Noor Hidayatallah, Institute of Tropical Medicine Antwerp
P009
Clinical pathology and diagnostic advances
Treatment of a dog with active tuberculosis (Poland)
Ewelina Szacawa, National Veterinary Research Institute in Pulawy, Poland
P010
Clinical pathology and diagnostic advances
Tuberculosis in alpacas in Poland in 2018-2019
Ewelina Szacawa, National Veterinary Research Institute in Pulawy, Poland
P011
Clinical pathology and diagnostic advances
Culture-Free Targeted Whole Genome Enrichment of Mycobacterium tuberculosis and Next-Generation Sequencing Enables Rapid Surveillance of Drug Resistance and Genomic Tracking.
Dylan Barbera, QIAGEN Sciences
P012
Clinical pathology and diagnostic advances
Detection of first-line and second-line Drug-Resistance mediating mutations in Mycobacterium tuberculosis with FluoroLyse and GenoXtract fleXT extracted DNA from sputum Using Next-Generation Sequencing
V Allerheiligen, Hain Lifescience GmbH - A Bruker company
P013
Clinical pathology and diagnostic advances
Impact of 'borderline' rpoB mutations on the MICs of Mycobacterium tuberculosis against new and repurposed anti-tuberculosis drugs
Praharshinie Rupasinghe, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp
P015
Clinical pathology and diagnostic advances
Overcoming barriers for non-tuberculous Mycobacteria identification: application of a culture-independent targeted sequencing approach
Ana Rita Macedo, National Reference Laboratory for Mycobacteria, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal
P016
Clinical pathology and diagnostic advances
Mycobacterium avium bacteriemia: direct identification and genotypic susceptibility characterization from positive blood culture bottles
Anna Camaggi, Laboratory of Microbiology and Virology, University Hospital “Maggiore della Carità”, Novara, Italy
P017
Clinical pathology and diagnostic advances
Isolation of Mycobacterium nebraskense in four oncolocic patients
Anna Camaggi, Laboratory of Microbiology and Virology, University Hospital “Maggiore della Carità”, Novara, Italy
P018
Clinical pathology and diagnostic advances
Widespread preexisting resistance to new and repurposed anti-tuberculosis drugs through loss-of-function
D Conkle-Gutierrez, San Diego State University
P019
Clinical pathology and diagnostic advances
Culture-free sequencing of M. tuberculosis: evaluating targeted and whole-genome approaches for genotyping and drug-resistance detection
Ilaria Iannucci, San Raffael Scientific Institute
P020
Clinical pathology and diagnostic advances
Big MAC: whole-genome sequencing uncovers novel members of the Mycobacterium avium complex unidentified at the species level by line-probe assays
Anders Norman, Statens Serum Institut
P021
Clinical pathology and diagnostic advances
Piloting Precision: Implementation of targeted next generation sequencing for antibiotic resistance testing into the diagnostic algorithm of Tuberculosis in Kyrgyzstan
Christian Utpatel, Research Center Borstel
P022
Clinical pathology and diagnostic advances
Acceptance of tongue swabs for tuberculosis screening among healthcare workers in Italy: a qualitative study
Renee CODSI, University of Washington
P023
Molecular Biology and Mycobacterial Evolution
Genetic characterisation of Mycobacterium bovis strains isolated from cattle in Northern Africa
Isabel Dickie, The Royal Veterinary College
P024
Clinical pathology and diagnostic advances
Rapidly and reproducibly building a catalogue of resistance-associated variants using 53,700 M. tuberculosis samples with genomes and DST data.
Dylan Adlard, University of Oxford
P025
Clinical pathology and diagnostic advances
Growth phase-specific DNA methylation bias in Mycobacterium tuberculosis clinical isolates
S J Modlin, San Diego State University
P026
Clinical pathology and diagnostic advances
Lung ultrasound for the detection of pulmonary tuberculosis using expert- and AI-guided interpretation: a prospective cohort study
Veronique Suttels, Lausanne University Hospital
P027
Clinical pathology and diagnostic advances
Subpopulations in clinical samples of M. tuberculosis can give rise to rifampicin resistance and shed light on how resistance was acquired
Viktoria Brunner, University of Oxford
P028
Clinical pathology and diagnostic advances
Emergence and reversion of rifampicin resistance during discontinuous treatment of tuberculosis in an HIV patient
Charlotte Genestet, International Center for Infectious Disease Research (CIRI), Lyon, France
P029
Clinical pathology and diagnostic advances
Use of large-scale clinical samples to progressively create a reference catalogue of mycobacterial species.
P W Fowler, University of Oxford
P030
Clinical pathology and diagnostic advances
Acceptability of tongue swabs for tuberculosis screening in migrant settings: A qualitative study with healthcare workers in Lombardy, Italy
Renee CODSI, University of Washington
P031
Clinical pathology and diagnostic advances
Rapid drug resistance prediction in positive Mycobacterium tuberculosis clinical samples using an extensive targeted next-generation sequencing panel
Rita Macedo, National Reference Laboratory for Mycobacteria, Infectious Diseases Department, National Institute of Health Doctor Ricardo Jorge
P032
Clinical pathology and diagnostic advances
Evaluation of new microdilution Plates (FRATMYC1 and FRATMYC2) for drug susceptibility testing to old and new antibiotics against slow growing non-tuberculous mycobacteria
Corentin Poignon, AP-HP Sorbonne University
P033
Clinical pathology and diagnostic advances
Evaluation of an Oxford Nanopore sequencing workflow for mycobacteria from primary MGIT culture
D W Crook, The University of Oxford
P034
Clinical pathology and diagnostic advances
Comparison of Illumina and Oxford Nanopore Technology sequencing of Mycobacterium tuberculosis
Matthew Colpus, Nuffield Department of Medicine, University of Oxford
P035
Clinical pathology and diagnostic advances
Stool based diagnostics for TB: who stands the benefit and how far are countries with the implementation.
Petra de haas, KNCV TB foundation
P036
Clinical pathology and diagnostic advances
A rapid DNA extraction method from clinical culture isolates for mycobacteria identification using INNO-LiPA mycobacteria v2.
Dennis Chye Sheng Gan, Duke-NUS Medical School
P037
Host-Pathogen interactions in TB
Exploring patterns of serum CRP level reduction in response to treatment initiation in Latvian patients with pulmonary tuberculosis: the impact of Mycobacterium tuberculosis genotype
Agnija Kivrane, Pharmacogenetic and Precision Medicine Laboratory, Pharmaceutical Education and Research Centre, Riga Stradins University, Konsula Street 21, LV1007 Riga, Latvia
P038
Host-Pathogen interactions in TB
Vitamin D receptor BsmI haplotype BB confers lower 25(OH)D levels during tuberculosis: A cross-sectional study
Dilcia Sambrano, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología
P039
Host-Pathogen interactions in TB
Chitosan-particle-based cystatin F RNA silencing as a therapeutic strategy to improve the control of intracellular Mycobacterium tuberculosis
Manoj Mandal, Host-Pathogen Interactions Unit, Research Institute for Medicines, Faculty of Pharmacy, University of Lisbon, Portugal
P040
Host-Pathogen interactions in TB
Redefining the role of the Signalling by Nuclear Receptors Pathway in Tuberculosis
Marta Silva, I3S- instituto de Investigação e Inovação em Saúde
P041
Host-Pathogen interactions in TB
Dueling forces: how glucocorticoids both help and hurt in tuberculosis.
Pablo Soldevilla, Unitat de Tuberculosi Experimental, Microbiology Dept. Germans Trias i Pujol Research Institute and Hospital (IGTP-HUGTIP), Badalona, 08916, Spain
P042
Host-Pathogen interactions in TB
Optimization of 3D culture conditions with five diferent tumor cell lines to monitor mycobacterial antitumor activity
Núria Sabando-Garcia, Universitat Autònoma de Barcelona
P043
Host-Pathogen interactions in TB
Exploring the role of Mincle in macrophage-mediated antitumoral responses
Noemí López Traba, Universitat Autònoma de Barcelona
P044
Host-Pathogen interactions in TB
In vitro modelling of the tuberculosis granuloma for antimicrobial and host-directed drug screening
David Pires, Center for Interdisciplinary Research in Health, Católica Medical School, Universidade Católica Portuguesa, Rio de Mouro 2635-631, Portugal
P045
Host-Pathogen interactions in TB
Phagocytosis of Mycobacterium fortuitum by caprine alveolar macrophages is associated with iNOS and proinflammatory marker expression
Miriam Blay Benach, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), IRTA, Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193, Catalonia, Spain.
P046
Host-Pathogen interactions in TB
Mycobacteria extracellular vesicles as alternative immunotherapy for Bladder cancer
Bazezew Yenew Tessema, Vita-Salute San Raffaele University, Milan, Italy
P047
Molecular Biology and Mycobacterial Evolution
Pattern of genotypic mutations and level of MIC for results evaluation of drug susceptibility testing of M. tuberculosis
N CIOBANU, Institute of Pneumology "Chiril Draganiuc"; Chisinau, Moldova
P048
Molecular Biology and Mycobacterial Evolution
A next-generation LLM-interrogable mycobacterial knowledge base
Klaas Dewaele, Institute of Tropical Medicine Antwerp
P049
Molecular Biology and Mycobacterial Evolution
Comparative analysis of nanopore and illumina sequencing for molecular epidemiology of M. tuberculosis
Viktoria Szel, National Reference Laboratory for Mycobacteriology, Hungary
P050
Molecular Biology and Mycobacterial Evolution
Improving the Reproducibility of RNA Sequencing Methodologies in Mycobacterium tuberculosis: A Pilot Study on Isoniazid Treatment
Trisha Parbhoo, Research Center Borstel, Leibniz Lung Centre
P051
Molecular Biology and Mycobacterial Evolution
Transcriptional plasticity of bedaquiline-resistant Mycobacterium tuberculosis under drug pressure
Teresa Walz, Research Center Borstel
P052
Molecular Biology and Mycobacterial Evolution
GOMA: an open-source bioinformatics pipeline for genomic characterization of Mycobacterium tuberculosis complex in low resource settings
Daniela Brites, Swiss Tropical and Public Health Institute
P053
Molecular Biology and Mycobacterial Evolution
Whole-genome sequencing for drug resistance detection and genotyping of clinical Mycobacterium tuberculosis isolates in two-year period
Eva Sodja, University Clinic Golnik
P054
Molecular Biology and Mycobacterial Evolution
Insights into Drug Resistance in Mycobacterium avium Pulmonary Disease: A Retrospective Cohort Study
Xenia Emilie Sinding Iversen, International Reference Laboratory of Mycobacteriology, Statens Serum Institute, 2300 Copenhagen S, Denmark.
P055
Molecular Biology and Mycobacterial Evolution
Benchmarking algorithms for species-level profiling of mycobacteria in shotgun metagenomic samples, and application to the distribution of known mycobacteria in soils
Luke Harrison, Centre Armand-Frappier Sante Biotechnologie - INRS
P056
Molecular Biology and Mycobacterial Evolution
Global Genomic Landscape of Mycobacterium avium: Diversity, Transmission Dynamics, and Drug Resistance Mechanisms
Sofia Matos, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
P057
Molecular Biology and Mycobacterial Evolution
In-depth analysis of predominant Mycobacterium tuberculosis L2.2.M3 strain from Panama, using TB-Annotator
Dilcia Sambrano, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología de Panamá
P058
Molecular Biology and Mycobacterial Evolution
When Bugs Spill Secrets: Leveraging Bacterial Genomes and Machine Learning to Identify Drivers of Recent Tuberculosis Transmission in Accra, Ghana
Marie Nancy Seraphin, University of Florida
P059
Molecular Biology and Mycobacterial Evolution
Comparison of DNA-extraction for Illumina and Oxford Nanopore Sequencing in Mycobacterial Isolates
Erik Michael Rasmussen, Statens Serum Institut, Copenhagen, Denmark
P060
Molecular Biology and Mycobacterial Evolution
The function and transcriptional regulation of M. tuberculosis efflux pumps
Robin Hanson, Royal Veterinary College, University of London
P061
Molecular Biology and Mycobacterial Evolution
RAVEN and iMAGE: An integrated approach to analyse and visualise whole genome data for Mycobacterium bovis genomic surveillance and epidemiology
Purnika Ranasinghe, Agri-Food and Biosciences Institute
P062
Molecular Biology and Mycobacterial Evolution
Comparing passed slave migration history to Mycobacterium tuberculosis genomic population structure to reconstruct the origins of L1 tuberculosis infections in Brazil
Christophe Sola, Université Paris-Saclay
P063
Molecular Biology and Mycobacterial Evolution
Secondary antibiotic resistance in rifampicin-resistant tuberculosis in a high-burden setting
Ori Solomon, McGill University
P064
Molecular Biology and Mycobacterial Evolution
Understanding tuberculosis transmission in Latvia: insights from molecular epidemiology
Renate Ranka, Latvian Biomedical Research and Study Centre
P065
Molecular Biology and Mycobacterial Evolution
Unexpected diversity in long-term infections by non-tuberculous mycobacteria revealed by longitudinal genomic analysis
Laura Pérez, Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, España
P066
Molecular Biology and Mycobacterial Evolution
Using the mutant selection window and mathematical modelling to predict resistance selection over long-term Mycobacterium tuberculosis treatment in vitro
Lindsay Sonnenkalb, Research Center Borstel Leibniz Lung Center
P067
Molecular Biology and Mycobacterial Evolution
Investigating antibiotic-induced persistence in Mycobacterium abscessus
Lisa Geerts, University of Antwerp
P069
Molecular Biology and Mycobacterial Evolution
An alternative for high-throughput Illumina-based sequencing: Individualized nanopore analysis of new incident cases coupled to targeted sequencing
S M Saleeb, Department of Clinical Microbiology and Infectious Diseases, Gregorio Marañón General University Hospital, Madrid, Spain
P070
Molecular Biology and Mycobacterial Evolution
An extended genomic analysis reveals unexpected transmissions involving the pediatric population in Madrid with tuberculosis
Marta López Llaría, Servicio de Microbiología clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, 28009, España
P071
Molecular Biology and Mycobacterial Evolution
Lineage-dependent rifampicin tolerance in Mycobacterium tuberculosis complex strains
Annemarie Hintz-Rüter, Research Center Borstel
P072
Molecular Biology and Mycobacterial Evolution
Genomic diversity of Mycobacterium abscessus isolates in Portugal
Miguel Pinto, Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal
P073
Molecular Biology and Mycobacterial Evolution
Genomic insights into Mycobacterium avium complex isolates from Portugal reveal extensive genetic diversity
Miguel Pinto, Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal
P074
Molecular Biology and Mycobacterial Evolution
Population structure of Mycobacterium tuberculosis Lineage 2 in Kazakhstan based on whole-genome sequencing
Sabina Atavliyeva, National Center for Biotechnology, Astana, Kazakhstan
P075
Molecular Biology and Mycobacterial Evolution
Do we use the right breakpoints for delamanid susceptibility testing ?
Noémie Lequerré, UPMC - Paris 6
P076
Molecular Biology and Mycobacterial Evolution
Emergence of bedaquiline resistance in samples rifampicin resistant Tuberculosis in Mozambique
Leonardo de Araujo, Research Center Borstel, Germany
P077
Molecular Biology and Mycobacterial Evolution
Relaunching crypticproject.org: making the MTBC genetic and pDST datasets collated by the CRyPTIC project more available to the wider community
Philip Fowler, University of Oxford
P078
Molecular Biology and Mycobacterial Evolution
Uncovering hidden complexity in TB infections: A novel WGS-based method for detecting mixed MTBC infections
Viola Dreyer, Research Center Borstel - Leibniz Lung Center
P079
Molecular Biology and Mycobacterial Evolution
Transcriptomic insight into metabolic adaptations and efflux-based mechanisms underlying bedaquiline resistance
Jihad Snobre, Institute of Tropical Medicine Antwerp
P080
Molecular Biology and Mycobacterial Evolution
Different paths to progress towards a faster and more precise genomic epidemiology in tuberculosis
S M Saleeb, Department of Clinical Microbiology and Infectious Diseases, Gregorio Marañón General University Hospital, Madrid, Spain
P081
Molecular Biology and Mycobacterial Evolution
Characterization of the putative cobalt ECF importer CbiMNQO and its cobalt/nickel dependent regulation by the ArsR/SmtB-like regulator CbiR in Mycobacterium smegmatis
Elke Goethe, University of Veterinary Medicine Hannover
P082
Molecular Biology and Mycobacterial Evolution
Improving the benchmark of variant calling of M. tuberculosis using more complex in silico genomes
Adrien Le Meur, University Paris - Saclay
P083
Molecular Biology and Mycobacterial Evolution
The nature and consequence of epistasis between drug resistance mutations in Mycobacterium tuberculosis
Sonia Borrell, Swiss Tropical and Public Health Institute
P084
Molecular Biology and Mycobacterial Evolution
Genomic description of routinely laboratory-diagnosed XDR-TB strains from 2010 to 2019 in the Western Cape Province, South Africa
Elizabeth Streicher, Stellenbosch Unversity
P085
Molecular Biology and Mycobacterial Evolution
Deciphering NucS interactions to explore anti-evolution strategies against Mycobacterium tuberculosis
Rima Zein Eddine, Laboratoire d'Optique et Biosciences (LOB), Ecole Polytechnique, Inserm U1182, CNRS UMR7645, Institut Polytechnique de Paris, 91120 Palaiseau, France.
P087
Molecular Biology and Mycobacterial Evolution
Strategies to detect emerging SNPs in clustered Mycobacterium tuberculosis isolates for precision epidemiology.
Richard Anthony, National Institute for Public Health and the Environment
P088
Molecular Biology and Mycobacterial Evolution
Evolutionary dynamics of MDR-TB and the escalation of drug resistance and clinical impact: a case study from Portugal
P Gomes, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisboa, Portugal
P089
Molecular Biology and Mycobacterial Evolution
Whole-genome sequencing-based surveillance system for Mycobacterium tuberculosis in Portugal
Miguel Pinto, Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal
P091
Molecular Biology and Mycobacterial Evolution
Endemic transmission of a Mycobacterium tuberculosis L2.2.M3 sublineage of the L2 lineage within Colon, Panama: a prospective study
Dilcia Sambrano, Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia Panama City Panama
P092
Molecular Biology and Mycobacterial Evolution
Genomic analysis of a novel nontuberculous mycobacterial isolate causing persistent, disseminated infection after cardiac transplantation
Jason Stout, Duke University School of Medicine
P094
Molecular Biology and Mycobacterial Evolution
Phylogenetics and ESX-1 characterisation of a new human pathotype in the Mycobacterium conceptionense / Mycobacterium senegalense clade
Arnold Piek, University Medical Center Groningen
P095
Neglected mycobacterial diseases
Twenty-three years surveillance of antimicrobial resistance in leprosy
Emmanuelle Cambau, Centre national de reference des mycobactéries et résistance aux antituberculeux (CNR-MyRMA)
P096
Neglected mycobacterial diseases
The drinking water-gut microbiome axis in NTM disease
Inês Cravo Roxo, Molecular Microbiology & Microbiome Group, CNC - Center for Neurosciences and Cell Biology and CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra
P097
Neglected mycobacterial diseases
Mycobacterium appelbergii sp. nov., a novel species isolated from a drinking water fountain in a rural community
Susana Alarico, CNC-UC - Center for Neuroscience and Cell Biology and CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Portugal
P098
Neglected mycobacterial diseases
Analyzing the mycolic acids (MAs) and lipids from the cell wall of Mycobacterium bovis strains isolated from Zacatecas and nearby regions.
Gloria Guillermina Guerrero Manriquez, Unidad Academica de Ciencias Biológicas. Universidad Autónoma de Zacatecas
P099
New generation vaccines for TB
Computational identification of broadly protective Mycobacterium tuberculosis vaccine candidate
SALEM SALMAN ALMUJRI, College of Pharmacy, King Khalid University
P100
New generation vaccines for TB
Identification of Mycobacterium avium Peptides Presented by Major Histocompatibility Complex Through Immunopeptidomics
Paulo Bettencourt, Faculty of Medicine, Universidade Católica Portuguesa, 2635-631 Rio de Mouro, Portugal
P101
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Detected cases of Mycobacterium tuberculosis infection in domestic and companion animals – indicators of epidemiological trends and health risks
Silvio Špicic, National Reference Laboratory for Animal Tuberculosis, Department for Bacteriology and Parasitology, Croatian Veterinary Institute, Zagreb, Croatia
P102
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
GenEpi-BioTrain: Interdisciplinary training in genomic epidemiology and public health bioinformatics: 5th edition (tuberculosis focus)
Ivan Barilar, Research Center Borstel Leibniz Lung Center
P103
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
The impact of environmental factors on tuberculosis in Albania, 2023–2024
Donika Mema, Institute of Public Health , Tirana, Albania
P104
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Linking long-term and short-term Mycobacterium tuberculosis transmission dynamics inferred form 15 years study in Orizaba, Mexico
Paula Sinisterra Sebastián, Tuberculosis Genomics Unit, Instituto de Biomedicina de Valencia, CSIC, Valencia, 46011 Spain
P105
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Tuberculosis Alert: a board game designed to promote tuberculosis awareness and fight stigma
Pablo Soldevilla, Unitat de Tuberculosi Experimental, Microbiology Dept. Germans Trias i Pujol Research Institute and Hospital (IGTP-HUGTIP), Badalona, 08916, Spain
P106
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Genomic Analysis of Mycobacterium chelonae isolates associated with heater-cooler units: a potential risk of infection during cardiac surgery
Simone Mok, Irish Mycobacteria Reference Laboratory, St. James’s Hospital, Dublin, Ireland
P107
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Applications and challenges of prospective whole genome sequencing for tuberculosis public health investigations: a systematic review.
Daisy Wang, Australian National University National Center for Epidemiology and Population Health
P108
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Recent updates to the SITVIT databases: ongoing development of the SITVITEXTEND and SITVITGeno projects
David Couvin, Institut Pasteur
P109
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
The impact, implementation, and ethics of whole genome sequencing for tuberculosis public health: staff perspectives from an outbreak in Victoria, Australia
Daisy Wang, National Center for Epidemiology and Population Health, Australian National University
P110
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
‘I was in a place where I was going to be healed. Let others think what they want’: A qualitative study on the experience of having tuberculosis in a sample of the Portuguese population
P Barbosa, EPIUnit ITR, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal
P111
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
A multinational Delphi consensus on TB screening of migrants in Europe
A Aguiar, EPIUnit ITR, Instituto de Saúde Pública da Universidade do Porto, Universidade do Porto, Rua das Taipas, n° 135, 4050-600 Porto, Portugal
P112
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Determining Epidemiological Cut-Off Values for BTZ-043 and Ganfeborole Using the EUCAST Reference Method
Arash Ghodousi, University Vita-Salute San Raffaele
P113
One Health Perspective on the Epidemiology, Environment, Lifestyle and Risk Factors for Mycobacteria Infection and Disease
Genomic Surveillance Uncovers Ongoing Tuberculosis Transmission in Catalonia (2022–2024).
Pere-Joan Cardona, Servei de Microbiologia, Laboratori Clínic Metropolitana Nord. Institut de Recerca i Hospital Germans Trias i Pujol (IGTP) – Badalona, Barcelona
P114
Systems Biology Approaches to Accelerate Mycobacteriosis Drug Discovery
Exploring LL-37-Based Synthetic Peptides to combat Multidrug-Resistant Tuberculosis: A step toward innovative therapies.
Paola Santos, Grupo Relaciones Microbianas y Epidemiológicas Aplicadas al Laboratorio Clínico y Molecular (REMA), Facultad de Ciencias de la Salud, Universidad Colegio Mayor de Cundinamarca, Bogotá, 110311, Colombia.
P115
Systems Biology Approaches to Accelerate Mycobacteriosis Drug Discovery
Validation of a cost-effective Drosophila melanogaster platform to identify novel treatments against tuberculosis
Maria Vidal Ramos, Unitat de Tuberculosi Experimental, Microbiology Dept. Germans Trias i Pujol Research Institute and Hospital (IGTP-HUGTIP), Badalona, 08916, Spain
P116
Systems Biology Approaches to Accelerate Mycobacteriosis Drug Discovery
Building a Large Dataset of Genome Mutations Associated with Antibiotic Resistance in Mycobacterium tuberculosis.
C Sola, INSERM, Universite Paris-Saclay
P117
Therapeutic strategies for NTM
In vitro activity of MRX-6038, a novel Leucyl-tRNA Synthetase inhibitor, against Mycobacterium abscessus
Michael Cynamon, Veteran’s Health Research Institute, Syracuse, NY
P118
Therapeutic strategies for NTM
Microbial Antagonism Against Nontuberculous Mycobacteria
Ana Maranha, CNC - Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, 3004-504 Coimbra, Portugal
